We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
(-46%)
Cap. Flow
-$438M
Cap. Flow
% of AUM
-78.37%
Top 10 Holdings %
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$25.1M |
| 2 |
Merck
MRK
|
+$9.57M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$9.37M |
| 4 |
BridgeBio Pharma
BBIO
|
+$9.02M |
| 5 |
Marvell Technology
MRVL
|
+$7.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.5M |
| 2 |
Citigroup
C
|
+$10.5M |
| 3 |
Microsoft
MSFT
|
+$9.87M |
| 4 |
OPTU
Optimum Communications Inc
OPTU
|
+$9.41M |
| 5 |
AES
AES
|
+$7.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.93% |
| 2 | Consumer Discretionary | 17.95% |
| 3 | Healthcare | 12.14% |
| 4 | Communication Services | 8.7% |
| 5 | Financials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Vontier
VNT
$4.73B
| $574K | 0.1% |
+18,686
| New | +$609K |
|
252
Edison International
EIX
$26.3B
| $573K | 0.1% |
8,400
-64,200
| -88% | -$4.07M |
|
253
Oracle
ORCL
$416B
| $571K | 0.1% |
+6,550
| New | +$615K |
|
254
Sunrun
RUN
$2.5B
| $568K | 0.1% |
+16,563
| New | +$775K |
|
255
KE Holdings
BEKE
$18.6B
| $567K | 0.1% |
28,197
-1,304
| -4% | -$26.7K |
|
256
Halliburton
HAL
$26.5B
| $565K | 0.1% |
24,719
-53,563
| -68% | -$1.27M |
|
257
Kinder Morgan
KMI
$69.3B
| $562K | 0.1% |
+35,421
| New | +$589K |
|
258
Levi Strauss
LEVI
$9.53B
| $562K | 0.1% |
22,436
-26,058
| -54% | -$672K |
|
259
Nokia
NOK
$53.5B
| $561K | 0.1% |
90,153
-1,055,536
| -92% | -$6.15M |
|
260
CareDx
CDNA
$2.35B
| $560K | 0.1% |
12,321
+9,087
| +281% | +$474K |
|
261
Chewy
CHWY
$9.84B
| $552K | 0.1% |
+9,359
| New | +$612K |
|
262
Gilead Sciences
GILD
$164B
| $548K | 0.1% |
+7,554
| New | +$520K |
|
|
BRSL
263
Brightstar Lottery PLC
BRSL
$2.08B
| $542K | 0.1% |
18,765
-95,434
| -84% | -$2.7M |
|
|
VNE
264
DELISTED
Veoneer, Inc.
VNE
| $531K | 0.1% |
14,957
-34,542
| -70% | -$1.22M |
|
265
Eastman Chemical
EMN
$8.39B
| $529K | 0.09% |
4,374
-2,697
| -38% | -$300K |
|
|
EVBG
266
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $527K | 0.09% |
+7,829
| New | +$947K |
|
267
Pultegroup
PHM
$25.3B
| $525K | 0.09% |
9,182
-17,831
| -66% | -$914K |
|
268
SS&C Technologies
SSNC
$18.6B
| $522K | 0.09% |
6,364
-47,256
| -88% | -$3.64M |
|
269
Vodafone
VOD
$35.4B
| $522K | 0.09% |
34,988
-44,101
| -56% | -$673K |
|
270
Mondelez International
MDLZ
$79.9B
| $521K | 0.09% |
+7,852
| New | +$485K |
|
271
Choice Hotels
CHH
$5.09B
| $513K | 0.09% |
+3,296
| New | +$473K |
|
272
Procore
PCOR
$8.46B
| $511K | 0.09% |
+6,393
| New | +$560K |
|
273
Alpha and Omega Semiconductor
AOSL
$974M
| $510K | 0.09% |
+8,427
| New | +$365K |
|
274
Fastly Inc
FSLY
$4.07B
| $506K | 0.09% |
+14,273
| New | +$621K |
|
275
Deere & Co
DE
$165B
| $504K | 0.09% |
+1,470
| New | +$511K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.
- Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
- Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
- Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
- Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
- Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
- Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
- Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.
Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.